Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06356337 · ClinicalTrials.gov registry record · NA
A Light Exposure Tracker Designed to Improve Circadian Rhythms - Aim 1
A NA study, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT06356337: Completed NA study, sponsored by Icahn School of Medicine at Mount Sinai.
NCT06356337 is a NA study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06356337, a NA study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this research study is to investigate the relationship between reminder messages sent via text and compliance with a daily morning light intervention designed to advance the circadian clock. Twenty healthy adults will be recruited to participate in a randomized, cross-over study where daily messages are, or are not, provided to remind participants to carry out the intervention.
Primary Outcome
Serial saliva samples will be collected to calculate dim light melatonin onset.
Interventions
- DEVICE Light goggles
- BEHAVIORAL Daily reminder test message
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2024-02-22 |
| Est. Completion | 2024-08-15 |
| Phase | NA |
What the finished NCT06356337 record still lists
NCT06356337 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Light goggles is the first listed.
NCT06356337 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06356337 about?
NCT06356337 is a clinical study titled "A Light Exposure Tracker Designed to Improve Circadian Rhythms - Aim 1". The purpose of this research study is to investigate the relationship between reminder messages sent via text and compliance with a daily morning light intervention designed to advance the circadian clock. Twenty healthy adults will be recruited to participate in a randomized, cross-over study where...
What is the current status of trial NCT06356337?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2024-02-22. Estimated completion is 2024-08-15.
What interventions are being tested in trial NCT06356337?
The interventions under investigation include: Light goggles (DEVICE), Daily reminder test message (BEHAVIORAL).
Who is sponsoring clinical trial NCT06356337?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06356337's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI